Search - CRCL-Virus hépatiques et pathobiologie des maladies chroniques hépatiques Access content directly

Filter your results

144 Results
Image document

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis

François Villeret , Fanny Lebossé , Sylvie Radenne , Didier Samuel , Bruno Roche , et al.
JHEP Reports Innovation in Hepatology, 2023, 5, ⟨10.1016/j.jhepr.2023.100728⟩
Journal articles hal-04158462v1

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Ali Chour , Julie Denis , Céline Mascaux , Maeva Zysman , Laurence Bigay-Game , et al.
Journal of Thoracic Oncology, 2023, ⟨10.1016/j.jtho.2023.05.013⟩
Journal articles hal-04158488v1

Sequence characterization of extracellular HBV RNA in patient plasma

Silvia Chang , Charlotte Hedskog , Bandita Parhy , Ross Martin , Hongmei Mo , et al.
Journal of Viral Hepatitis, 2023, 30 (1), pp.29-38. ⟨10.1111/jvh.13760⟩
Journal articles hal-04013318v1

From large-for-size to large-for-flow: A paradigm shift in liver transplantation

Guillaume Rossignol , Xavier Muller , Joris Couillerot , Fanny Lebossé , Marie-Charlotte Delignette , et al.
Liver Transplantation, 2023, Publish Ahead of Print, ⟨10.1097/LVT.0000000000000150⟩
Journal articles hal-04158439v1
Image document

Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity

Anne-Flore Legrand , Julie Lucifora , Benoît Lacombe , Camille Ménard , Maud Michelet , et al.
Hepatology Communications, 2023, 7 (5), pp.e0078. ⟨10.1097/HC9.0000000000000078⟩
Journal articles hal-04072355v1
Image document

Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms

Julie Lucifora , Dulce Alfaiate , Caroline Pons , Maud Michelet , Ricardo Ramirez , et al.
Journal of Hepatology, In press, ⟨10.1016/j.jhep.2023.01.005⟩
Journal articles hal-03992721v1
Image document

Assessment of neutrophil subsets and immune checkpoint inhibitor expressions on T lymphocytes in liver transplantation: A preliminary study beyond the neutrophil-lymphocyte ratio

Arnaud Riff , Muzhda Haem Rahimi , Marie-Charlotte Delignette , Morgane Gossez , Rémy Coudereau , et al.
Frontiers in Physiology, 2023, 14, pp.1095723. ⟨10.3389/fphys.2023.1095723⟩
Journal articles hal-04115485v1

Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008–2012: A cross-sectional study

Stéphane Chevaliez , Françoise Roudot-Thoraval , Cécile Brouard , Emmanuel Gordien , Fabien Zoulim , et al.
JHEP Reports Innovation in Hepatology, 2022, 4 (12), pp.100593. ⟨10.1016/j.jhepr.2022.100593⟩
Journal articles hal-04013356v1

Nomenclature of HBV core protein-targeting antivirals

Fabien Zoulim , Adam Zlotnick , Stephanie Buchholz , Eric Donaldson , John Fry , et al.
Nature reviews. Gastroenterology & hepatology, 2022, 19 (12), pp.748-750. ⟨10.1038/s41575-022-00700-z⟩
Journal articles hal-04013315v1

Gene Editing Technologies to Target HBV cccDNA

Maria Guadalupe Martinez , Elena Smekalova , Emmanuel Combe , Francine Gregoire , Fabien Zoulim , et al.
Viruses, 2022, 14 (12), pp.2654. ⟨10.3390/v14122654⟩
Journal articles hal-04013365v1

Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension

Elisabetta Degasperi , Maria Paola Anolli , Sara Colonia Uceda Renteria , Dana Sambarino , Marta Borghi , et al.
Journal of Hepatology, 2022, 77 (6), pp.1525-1531. ⟨10.1016/j.jhep.2022.07.016⟩
Journal articles hal-04013314v1
Image document

Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa

Jeanne Perpétue Vincent , Gibril Ndow , Shintaro Ogawa , Amie Ceesay , Ramou Njie , et al.
Journal of Global Health, 2022, 12, pp.04076. ⟨10.7189/jogh.12.04076⟩
Journal articles hal-04008675v1

Viral hepatitis elimination: Towards a hepatitis-free world

Maria Buti , Antonio Craxi , Graham Foster , Mojca Maticic , Francesco Negro , et al.
Journal of Hepatology, 2022, 77 (5), pp.1444-1447. ⟨10.1016/j.jhep.2022.06.034⟩
Journal articles hal-04013306v1

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

Anna Kramvis , Kyong-Mi Chang , Maura Dandri , Patrizia Farci , Dieter Glebe , et al.
Nature reviews. Gastroenterology & hepatology, 2022, 19 (11), pp.727-745. ⟨10.1038/s41575-022-00649-z⟩
Journal articles hal-04013304v1

Significance of serum HBV RNA in non‐cirrhotic HBeAg ‐negative chronic hepatitis B patients who discontinue effective antiviral therapy

Margarita Papatheodoridi , Eleni Papachristou , Zissis Moschidis , Emilia Hadziyannis , Eirini Rigopoulou , et al.
Journal of Viral Hepatitis, 2022, 29 (11), pp.948-957. ⟨10.1111/jvh.13729⟩
Journal articles hal-04013299v1

Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries

Amie Ceesay , Khaled Bouherrou , Boun Kim Tan , Maud Lemoine , Gibril Ndow , et al.
Microorganisms, 2022, 10 (11), pp.2096. ⟨10.3390/microorganisms10112096⟩
Journal articles hal-04008671v1
Image document

HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme

Amina Sow , Maud Lemoine , Papa Souleymane Toure , Madoky Diop , Gora Lo , et al.
JHEP Reports Innovation in Hepatology, 2022, 4 (10), pp.100533. ⟨10.1016/j.jhepr.2022.100533⟩
Journal articles hal-04008661v1
Image document

Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes

Manon Desmares , Marion Delphin , Brieux Chardès , Caroline Pons , Juliette Riedinger , et al.
Antiviral Research, 2022, 206, pp.105386. ⟨10.1016/j.antiviral.2022.105386⟩
Journal articles hal-03869860v1

Poly(ADP-Ribose) Polymerase Inhibition as a Promising Approach for Hepatocellular Carcinoma Therapy

Alexia Paturel , Janet Hall , Isabelle Chemin
Cancers, 2022, 14 (15), pp.3806. ⟨10.3390/cancers14153806⟩
Journal articles hal-04008652v1

Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection

Tobias Boettler , Upkar Gill , Lena Allweiss , Teresa Pollicino , John Tavis , et al.
JHEP Reports Innovation in Hepatology, 2022, 4 (6), pp.100480. ⟨10.1016/j.jhepr.2022.100480⟩
Journal articles hal-04013126v1

Performance of the cobas® HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients

Caroline Scholtès , Aaron Hamilton , Marie‐laure Plissonnier , Caroline Charre , Beth Scott , et al.
Journal of Clinical Virology, 2022, 150-151, pp.105150. ⟨10.1016/j.jcv.2022.105150⟩
Journal articles hal-04013121v1

Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B

Heejoon Jang , Jun Sik Yoon , Soo Young Park , Han Ah Lee , Myoung-Jin Jang , et al.
Clinical Gastroenterology and Hepatology, 2022, 20 (6), pp.1343-1353.e16. ⟨10.1016/j.cgh.2021.09.001⟩
Journal articles hal-04012226v1

Clinical utility of the 'Determine HBsAg' Point-of-Care Test for Diagnosis of Hepatitis B Surface Antigen in Africa

Amie Ceesay , Maud Lemoine , Damien Cohen , Isabelle Chemin , Gibril Ndow
Expert Review of Molecular Diagnostics, 2022, 22 (5), pp.497-505. ⟨10.1080/14737159.2022.2076595⟩
Journal articles hal-04008646v1

Editorial: screening for hepatocellular carcinoma in NAFLD —towards abbreviated MRI alternative in patients with obesity?

Fanny Lebossé , Cyrielle Caussy
Alimentary Pharmacology & Therapeutics (Suppl), 2022, 55 (9), pp.1210-1211. ⟨10.1111/apt.16887⟩
Journal articles hal-03658960v1

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

Milan Sonneveld , Shao-Ming Chiu , Jun Yong Park , Sylvia Brakenhoff , Apichat Kaewdech , et al.
Journal of Hepatology, 2022, 76 (5), pp.1042-1050. ⟨10.1016/j.jhep.2022.01.007⟩
Journal articles hal-04013069v1

CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants

Maria Guadalupe Martinez , Emmanuel Combe , Aurore Inchauspe , Philippe Emmanuel Mangeot , Elodie Delberghe , et al.
mBio, 2022, 13 (2), ⟨10.1128/mbio.02888-21⟩
Journal articles hal-04013092v1

Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)

Milan Sonneveld , Jun Yong Park , Apichat Kaewdech , Wai-Kay Seto , Yasuhito Tanaka , et al.
Clinical Gastroenterology and Hepatology, 2022, 20 (4), pp.e784-e793. ⟨10.1016/j.cgh.2020.12.005⟩
Journal articles hal-04012155v1
Image document

Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)

Tangui Barré , Hélène Fontaine , Clémence Ramier , Vincent Di Beo , Stanislas Pol , et al.
Clinical Nutrition, 2022, 41 (3), pp.610-619. ⟨10.1016/j.clnu.2022.01.016⟩
Journal articles hal-03776967v1

Special Issue: “Updates on HBV Infection”

Isabelle Chemin , Flor Helene Pujol
Microorganisms, 2022, 10 (3), pp.580. ⟨10.3390/microorganisms10030580⟩
Journal articles hal-04008639v1

Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis

Alessandro Loglio , Peter Ferenci , Sara Colonia Uceda Renteria , Christine Y.L. Tham , Caroline Scholtes , et al.
Journal of Hepatology, 2022, 76 (2), pp.464-469. ⟨10.1016/j.jhep.2021.10.012⟩
Journal articles hal-04012236v1